Functional Heterogeneity of Hepatitis B Virus-Specific CD8+ T Cells Mediates the Clinical Outcomes of Infection
Open Access
- 21 May 2026
- journal article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (5) , 51459
Abstract
Background: Hepatitis B virus (HBV)-specific CD8+ T cells play a crucial role in viral clearance. However, in patients with chronic hepatitis B infections, sustained immune activation leads to functional impairment of these HBV-specific CD8+ T cells. The goal of this study was to clarify whether these virus-specific CD8+ T cells are exhausted or reflect an incomplete response derived from the initial T cell repertoire. Methods: In this study, HBV core 18–27 epitope-specific CD8+ T cells were identified by proliferation through in vitro antigen stimulation. Peptide-specific CD8+ T cells recognizing the cytomegalovirus (CMV) pp65 495–503 epitope were used as a positive control, as they exhibit a robust immune response. Single-cell sequencing was employed to characterize the TCR repertoire of expanded clones. Correlations between T cell subsets and clinical outcomes were analyzed and compared. Results: Both HBV core 18–27-specific and CMV pp65-specific CD8+ T cells were successfully classified into three functionally distinct subsets: IFNγ+, mTGFβ+, and IFNγ–/mTGFβ–. Those patients with resolved acute HBV infections and HBV core 18–27 specific CD8+ T cells exhibited the highest IFNγ+/mTGFβ+ ratio, reaching levels comparable to those of CMV pp65-specific CD8+ T cells. Inactive HBV carriers exhibited the second-highest IFNγ+/mTGFβ+ ratio, while this ratio was lowest among patients exhibiting viral immune tolerance. HBV core 18–27 tetramer staining and ERGO-Ⅱ Model prediction demonstrated that IFNγ+ subset CD8+ T cells exhibited the highest affinity for this epitope, followed by the mTGFβ+ subset, with IFNγ–/mTGFβ– cells exhibiting the lowest affinity. Conclusions: These results suggest that individuals with a high IFNγ+/mTGFβ+ ratio exhibit a lower HBV viral load. The IFNγ+/mTGFβ+ CD8+ T cell ratio, in particular, appears to be associated with HBV clearance, and this may be attributable to T cell receptor affinity for HBV epitopes.Keywords
Funding Information
- National Natural Science Foundation of China (81871226)
- National Natural Science Foundation of China (32170920)
- Research Foundation of the Health Commission of Hubei Province Scientific Research Project, China (WJ2021F134)
This publication has 54 references indexed in Scilit:
- T cell receptor sequences are the dominant factor contributing to the phenotype of CD8+ T cells with specificities against immunogenic viral antigensCell Reports, 2023
- Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis BHepatology International, 2023
- Immune‐Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B–Infected CellsHepatology, 2020
- Transforming Growth Factor-β Signaling in Immunity and CancerImmunity, 2019
- Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanismsCellular Immunology, 2017
- Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8+ TCR Repertoires to Immunodominant Viral AntigensCell Reports, 2017
- Interferon Regulatory Factor 4 Sustains CD8+ T Cell Expansion and Effector DifferentiationImmunity, 2013
- The high prevalence of the I27 mutant HBcAg18–27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitopeClinical Immunology, 2007
- Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: Interaction with HLA and T-cell receptorHepatology, 1997
- Selective activation of resting human γδ T lymphocytes by interleukin‐2European Journal of Immunology, 1993